[1]
Gontijo, M.F. da M.S.V. et al. 2025. Epidemiological and clinicopathological parameters related to the neoadjuvant chemotherapy for breast cancer during the COVID-19 crisis. Mastology. 35, (Sep. 2025). DOI:https://doi.org/10.29289/2594539420240007.